FDA Approves New Generic Version of Abortion Drug Mifepristone as Agency Continues Safety Review

FDA Approves New Generic Version of Abortion Drug Mifepristone as Agency Continues Safety Review


The U.S. Food and Drug Administration (FDA) approved a new generic version of the abortion pill on Tuesday, prompting outrage from conservatives and the pro-life movement. 

The FDA’s approval of a generic form of mifepristone — the first drug used in a two-drug medication abortion regimen — comes as the agency, under the direction of the Department of Health and Human Services (HHS), is performing a safety review of the drug following a shocking study suggesting a much higher complication rate than previously reported. 

The FDA specifically approved a generic form of the abortion pill produced by Evita Solutions LLC, a company that says its mission is to “normalize abortion” and make it “accessible to all.” In the FDA’s letter to Evita Solutions LLC, the

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!